Translational and Clinical Pharmacology

短名Transl Clin Pharmacol
Journal Impact1.13
国际分区PHARMACOLOGY & PHARMACY(Q4)
ISSN2289-0882, 2383-5427
h-index12

Translational and Clinical Pharmacology (Transl Clin Pharmacol, TCP) is the official journal of the Korean Society for Clinical Pharmacology and Therapeutics (KSCPT). TCP is an interdisciplinary journal devoted to the dissemination of knowledge relating to all aspects of translational and clinical pharmacology. The categories for publication include pharmacokinetics (PK) and drug disposition, drug metabolism, pharmacodynamics (PD), clinical trials and design issues, pharmacogenomics and pharmacogenetics, pharmacometrics, pharmacoepidemiology, pharmacovigilence, and human pharmacology. Studies involving animal models, pharmacological characterization, and clinical trials are appropriate for consideration.

涉及主题医学生物内科学药理学生物信息学化学药代动力学内分泌学生物化学心理学病理精神科计算机科学数学有机化学遗传学物理统计生物利用度
出版信息出版商: Korean Society for Clinical Pharmacology and Therapeutics出版周期: 期刊类型: journal
基本数据创刊年份: 2014原创研究文献占比90.91%自引率:0.00%Gold OA占比: 100.00%

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

Development of <i>in-silico</i> drug cardiac toxicity evaluation system with consideration of inter-individual variability

2024-1-1

Data science through natural language with ChatGPT’s Code Interpreter

2024-1-1

Pharmacokinetics and bioequivalence study of candesartan cilexetil tablet in Chinese volunteers under fasting condition: an open-label, randomized-sequence, 2-period crossover study

2024-1-1

Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects

2024-1-1

Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials

2024-1-1

Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing

2024-1-1

The effects of opium consumption on severity of disease on hospitalized COVID‐19 patients in East of Iran, a prospective cohort study

2024-1-1

Emerging and upcoming therapies in insomnia

2024-1-1

The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance

2024-1-1

Detection and analysis of plasma lncRNA, miRNA and mRNA profile in preterm birth with intraventricular hemorrhage

2024-1-1

Effects of rifampin coadministration on the pharmacokinetics of digoxin: a real-world data approach

2023-1-1

Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function

2023-1-1

Effects of three-dimensional image based insole for healthy volunteers: a pilot clinical trial

2023-1-1

Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects

2023-1-1

Quantification of OATP1B1 endogenous metabolites coproporphyrin I and III in human urine

2023-1-1

Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation

2023-1-1

Analysis of the distribution of trial sites in South Korea using social network analysis

2023-1-1

What goes in the regulatory clinical pharmacology package for an oncolytic virus?

2023-1-1

Likelihood interval for nonlinear regression

2023-1-1

Transforming clinical trials: the emerging roles of large language models

2023-1-1

A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy

2023-1-1

A review of the Bayesian approach with the MCMC and the HMC as a competitor of classical likelihood statistics for pharmacometricians

2023-1-1

Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers

2023-1-1

Pharmacokinetics of low doses of colchicine in the leukocytes of Japanese healthy individuals

2023-1-1

Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertension

2023-1-1

Impact of antioxidants in improving semen parameters like count, motility and DNA fragmentation in sub-fertile males: a randomized, double-blind, placebo-controlled clinical trial

2023-1-1

Phage-host-immune system dynamics in bacteriophage therapy: basic principles and mathematical models

2023-1-1

Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects

2023-1-1

Adaptive design clinical trials: current status by disease and trial phase in various perspectives

2023-1-1

Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects

2023-1-1

Efficacy and safety assessment of protein supplement - micronutrient fortification in promoting health and wellbeing in healthy adults - a randomized placebo-controlled trial

2023-1-1

Lessons from a multicenter clinical trial with an approved wearable electrocardiogram: issues and practical considerations

2022-1-1

Evaluation of food effects on the pharmacokinetics of <i>Pelargonium sidoides</i> and <i>Coptis</i> with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects

2022-1-1

Melatonin and melatonergic drugs in sleep disorders

2022-1-1

A case of sinus arrest in atrial fibrillation with pulmonary embolism after flecainide ingestion

2022-1-1

Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs

2022-1-1

Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS)

2022-1-1

Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination

2022-1-1

Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19

2022-1-1

Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report

2022-1-1

Implementation of Miettinen-Nurminen score method with or without stratification in R

2022-1-1

Common<i>ABCB1</i>SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject

2022-1-1

Factors influencing decision making and antibiotic prescribing patterns for the treatment of carbapenem-resistant <i>Enterobacteriaceae</i> (CRE) among non-infectious physicians in Thailand: a qualitative study

2022-1-1

A simple time-to-event model with NONMEM featuring right-censoring

2022-1-1

Predicting the systemic exposure and lung concentration of nafamostat using physiologically-based pharmacokinetic modeling

2022-1-1

How to boost and accelerate new drug development in Korea: business ecosystem perspectives

2022-1-1

A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers

2022-1-1

Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditions

2022-1-1

Prediction of metabolizing enzyme-mediated clinical drug interactions using <i>in vitro</i> information

2022-1-1

Ultrafast liquid chromatography-tandem mass spectrometry determination of donepezil in human plasma: application to a bioequivalence study

2022-1-1

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司